see here

first_text= Symposium: Recombinant Epo therapy - advantages in the structure and the physiological profile 9.10.2008, Sofia Symposium: VELCADE – proven efficacy extending the opportunities for therapy of multiple myeloma 27.09.2007, Varna TOPAMAX - wide-spectrum anticonvulsant in adolesence as an added therapy and monotherapy 29.10.2004, Plovdiv
second_text=fs_33
ref_load=